Key considerations in a meta-analysis of physiology-guided percutaneous vs surgical revascularization in multivessel coronary artery disease

Read full text Summarise with VIRAT
Authors: Tsung-Ying Tsai, Scot Garg, Patrick W.J.C. Serruys
Cited by: 0
References: 4

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We read the meta-analysis by Kataveni et al with great interest; however, we have identified two major methodological errors. First, the population from the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3 (FAME 3) trial appears to have been double-counted through inclusion of both Fearon et al (primary FAME 3 trial) and Dillen et al (a FAME 3 bifurcation substudy), likely violating the independence assumptions required for meta-analytic pooling. Second, the study by Di Gioia et al (2020) has been misclassified as a randomized controlled trial, whereas it is a registry-based, non-randomized study. Because the authors’ conclusions rely on the inclusion of “three randomized controlled trials” with minimal heterogeneity, these errors may overstate the certainty of the evidence and introduce bias into the pooled estimates. We request that the authors address these concerns, perform a re-analysis as required, and revise the manuscript accordingly. Ultimately, these issues reflect the general paucity of high-quality randomized data in this field.

Fields of Study & Subjects

Coronary Interventions and Diagnostics Cardiac Imaging and Diagnostics Meta-analysis and systematic reviews

Publication details

Journal / source
World Journal of Cardiology
Volume
18
Issue
3
Publication date
23 March 2026
Language
EN